Literature DB >> 16237056

TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1.

Il-Kyoo Park1, Leonard D Shultz, John J Letterio, James D Gorham.   

Abstract

TGF-beta1 prevents the development of autoimmune disease by restraining the development of autoreactive Th1 cells. TGF-beta1 inhibits Th1 development in part by suppressing the expression of T-bet, an IFN-gamma-induced transcription factor that promotes Th1 differentiation, but how TGF-beta1 suppresses T-bet is not known. In this study we show that TGF-beta1 suppresses IFN-gamma-induced T-bet expression through the hemopoietic protein tyrosine phosphatase (PTP) Src homology region 2 domain-containing phosphatase-1 (Shp-1). In murine CD4+ T cells, IFN-gamma rapidly induced the expression of T-bet as well as of IFN regulatory factor-1, another transcription factor important for Th1 development. TGF-beta1 antagonized the effects of IFN-gamma, inhibiting IFN-gamma's induction of both Th1 transcription factors. In the presence of IFN-gamma, TGF-beta1 rapidly induced in Th cells the synthesis of the PTP Shp-1, but did not induce Shp-2 or several members of the suppressor of cytokine signaling family of Jak-Stat inhibitors. We tested the requirement for Shp-1 by using T cells from the Shp-1-deficient me(v)/me(v) mouse strain. Shp-1 was required for TGF-beta1's suppressive effects, because its suppression of T-bet and IFN regulatory factor-1 was completely abrogated in me(v)/me(v) CD4+ T cells. Receptor-proximal responses to IFN-gamma, such as the induction of Jak-Stat phosphorylation, were inhibited by TGF-beta1 in wild-type T cells, but not in me(v)/me(v) T cells. Consistent with a direct role for Shp-1, TGF-beta1's inhibition of IFN-gamma-induced Stat1 phosphorylation was sensitive to the general PTP inhibitor pervanadate. Together, these data show that TGF-beta1 suppresses IFN-gamma signaling and transcriptional responses in CD4+ T cells through the PTP Shp-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237056     DOI: 10.4049/jimmunol.175.9.5666

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

3.  Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.

Authors:  Bin Su; Marina Elizabeth Biedma; Alexandre Lederle; Maryse Peressin; Mélanie Lambotin; Alizé Proust; Thomas Decoville; Sylvie Schmidt; Géraldine Laumond; Christiane Moog
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 4.  TGFbeta1 and Treg cells: alliance for tolerance.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2007-10-30       Impact factor: 11.951

5.  T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.

Authors:  Amanda A Melillo; Oded Foreman; Catharine M Bosio; Karen L Elkins
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

6.  Impaired interferon signaling is a common immune defect in human cancer.

Authors:  Rebecca J Critchley-Thorne; Diana L Simons; Ning Yan; Andrea K Miyahira; Frederick M Dirbas; Denise L Johnson; Susan M Swetter; Robert W Carlson; George A Fisher; Albert Koong; Susan Holmes; Peter P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

7.  T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis.

Authors:  Richard K S Phoon; A Richard Kitching; Dragana Odobasic; Lynelle K Jones; Timothy J Semple; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 8.  Th17 cells: from precursors to players in inflammation and infection.

Authors:  Amit Awasthi; Vijay K Kuchroo
Journal:  Int Immunol       Date:  2009-03-04       Impact factor: 4.823

9.  STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.

Authors:  Hiromi Takaki; Kenji Ichiyama; Keiko Koga; Takatoshi Chinen; Giichi Takaesu; Yuki Sugiyama; Shigeaki Kato; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-04-09       Impact factor: 5.157

10.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

Authors:  Yuhong Yang; Jeffrey Weiner; Yue Liu; Alan J Smith; David J Huss; Ryan Winger; Haiyan Peng; Petra D Cravens; Michael K Racke; Amy E Lovett-Racke
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.